Teebacin

   
Google
 
Web NewDrugInformation.com

Teebacin


Drug - Teebacin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Aminosalicylate Sodium
Multiple ingredients are in alphabetical order.

Strength - 500MG
The potency of the active ingredient(s), Aminosalicylate Sodium. May repeat for multiple part products.

Applicant - CONSOLIDATED MIDLAND
The firm name holding legal responsibility for Teebacin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 007320
The FDA assigned number to Teebacin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Teebacin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Teebacin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Teebacin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Teebacin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Consolidated Midland Corp
The full name of the firm holding legal responsibility for the new application of Teebacin.

Teebacin